1. Home
  2. WTTR vs TARS Comparison

WTTR vs TARS Comparison

Compare WTTR & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Select Water Solutions Inc.

WTTR

Select Water Solutions Inc.

HOLD

Current Price

$20.17

Market Cap

2.5B

Sector

Energy

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$58.66

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTTR
TARS
Founded
2016
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Oilfield Services/Equipment
Medicinal Chemicals and Botanical Products
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.7B
IPO Year
2017
2020

Fundamental Metrics

Financial Performance
Metric
WTTR
TARS
Price
$20.17
$58.66
Analyst Decision
Strong Buy
Buy
Analyst Count
3
6
Target Price
$16.67
$89.00
AVG Volume (30 Days)
1.8M
1.4M
Earning Date
05-05-2026
05-06-2026
Dividend Yield
1.65%
N/A
EPS Growth
N/A
48.21
EPS
N/A
N/A
Revenue
$1,528,930,000.00
$451,360,000.00
Revenue This Year
$2.11
$56.43
Revenue Next Year
$4.94
$30.19
P/E Ratio
$69.16
N/A
Revenue Growth
120.79
146.71
52 Week Low
$7.86
$38.51
52 Week High
$21.67
$85.25

Technical Indicators

Market Signals
Indicator
WTTR
TARS
Relative Strength Index (RSI) 55.36 45.13
Support Level $17.60 $56.05
Resistance Level $20.27 $67.14
Average True Range (ATR) 0.80 3.54
MACD 0.08 -0.35
Stochastic Oscillator 60.21 23.72

Price Performance

Historical Comparison
WTTR
TARS

About WTTR Select Water Solutions Inc.

Select Water Solutions Inc provides sustainable water-management solutions to the energy industry in the United States. These solutions are supported by the company's critical water infrastructure assets, chemical manufacturing, and water treatment and recycling capabilities. The company's reportable segments are Water Services, Water Infrastructure, and Chemical Technologies. It generates maximum revenue from the Water Services segment, which comprises its short-cycle, field-based service offerings, including water transfer, water sourcing, fluids hauling, monitoring, containment, water-network automation, and the services associated with Peak Rentals. This segment earns revenue via market-based day rates, time-and-materials, or per-barrel delivered under MSAs and short-term work orders.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: